Related Experiment Video
Updated: Nov 4, 2025

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
Roles of APOBEC3 in hepatitis B virus (HBV) infection and hepatocarcinogenesis
Yuan Zhang1, Xiaorong Chen1, Yajuan Cao2,3
1Department of Integrative Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Insights
APOBEC3 (A3) enzymes fight hepatitis B virus (HBV) but can also cause genetic mutations. Aberrant A3 activity linked to cancer development, highlighting their dual role in immunity and genomic stability.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- APOBEC3 (A3) cytidine deaminases are crucial for innate immunity and regulate protein expression.
- A3 enzymes exhibit dual activity, inhibiting hepatitis B virus (HBV) while also posing risks to genomic stability.
- Dysregulated A3 gene expression is implicated in pathological conditions and cancer development.
Purpose of the Study:
- To review the antiviral functions and mechanisms of A3 editing enzymes against HBV infection.
- To explore the association between A3 genes and the development of liver cancer (hepatocarcinogenesis).
Main Methods:
- Literature review of studies on APOBEC3 enzymes and HBV.
- Analysis of research linking A3 gene dysregulation to cancer.
- Synthesis of information on biochemical activities and cellular roles of A3 proteins.
Main Results:
- A3 enzymes demonstrate significant antiviral activity against HBV through specific biochemical mechanisms.
- The deaminating activity of A3 proteins on single-stranded DNA can lead to mutations, impacting genomic integrity.
- Aberrant A3 expression and activity are correlated with increased risk of hepatocarcinogenesis.
Conclusions:
- APOBEC3 enzymes are key players in antiviral defense against HBV, but their mutagenic potential necessitates careful regulation.
- Understanding the dual role of A3 enzymes is critical for developing therapeutic strategies against HBV and preventing associated cancers.
Abstract:
APOBEC3 (A3) cytidine deaminases inhibit hepatitis B virus (HBV) infection and play vital roles in maintaining a variety of biochemical processes, including the regulation of protein expression and innate immunity. Emerging evidence indicates that the deaminated deoxycytidine biochemical activity of A3 proteins in single-stranded DNA makes them a double-edged sword. These enzymes can cause cellular genetic mutations at replication forks or within transcription bubbles, depending on the physiological state of the cell and the phase of the cell cycle. Under pathological conditions, aberrant expression of A3 genes with improper deaminase activity regulation may threaten genomic stability and eventually lead to cancer development. This review attempted to summarize the antiviral activities and underlying mechanisms of A3 editing enzymes in HBV infections. Moreover, the correlations between A3 genes and hepatocarcinogenesis were also elucidated.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Abnormal Proliferation
The Intrinsic Apoptotic Pathway